Charles River Laboratories International (CRL) News Today $106.41 +6.66 (+6.68%) As of 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Charles River Laboratories International Inc (CRL) Shares Up 5.39% on Apr 14April 14 at 1:59 PM | gurufocus.comGrandeur Peak Global Advisors LLC Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Grandeur Peak Global Advisors LLC lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 40.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 30,055 shares of theApril 14 at 7:15 AM | marketbeat.comAPG Asset Management N.V. Acquires 22,349 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)APG Asset Management N.V. lifted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 288.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor ownedApril 14 at 5:22 AM | marketbeat.comInvesco Ltd. Grows Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Invesco Ltd. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,034,180 shares of the medicalApril 14 at 4:57 AM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Sees Large Volume Increase - Here's What HappenedCharles River Laboratories International (NYSE:CRL) Sees Large Volume Increase - Time to Buy?April 13 at 1:14 PM | marketbeat.comZacks Research Brokers Decrease Earnings Estimates for CRLCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Equities research analysts at Zacks Research dropped their Q1 2025 earnings per share estimates for Charles River Laboratories International in a research report issued on Thursday, April 10th. Zacks Research analyst R. DepApril 13 at 7:28 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Kennedy Capital Management LLCKennedy Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 21.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor oApril 13 at 6:46 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stake Reduced by Envestnet Asset Management Inc.Envestnet Asset Management Inc. decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 14.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor ownedApril 13 at 5:08 AM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Sees Large Volume Increase - Still a Buy?April 13 at 4:05 AM | americanbankingnews.comCharles River Gets Hit By The FDA, Too Early To Bet On A ComebackApril 12 at 8:15 AM | seekingalpha.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Boosted by Aviva PLCAviva PLC lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1,508.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 31,069 shares of the medical research company's stock after acquiring an additionalApril 12 at 5:10 AM | marketbeat.comResona Asset Management Co. Ltd. Purchases Shares of 15,327 Charles River Laboratories International, Inc. (NYSE:CRL)Resona Asset Management Co. Ltd. purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 15,327 sharesApril 12 at 5:06 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Holdings Decreased by Alliancebernstein L.P.Alliancebernstein L.P. trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 24.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 64,029 shares of the medical research company'sApril 12 at 4:29 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Lowered by Orion Portfolio Solutions LLCOrion Portfolio Solutions LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 57.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,390 shares of the medical research cApril 12 at 4:10 AM | marketbeat.comMizuho Has Lowered Expectations for Charles River Laboratories International (NYSE:CRL) Stock PriceApril 12 at 2:51 AM | americanbankingnews.comCharles River Laboratories International (NYSE:CRL) Price Target Lowered to $155.00 at MizuhoMizuho lowered their target price on Charles River Laboratories International from $175.00 to $155.00 and set a "neutral" rating for the company in a research note on Wednesday.April 11 at 8:12 AM | marketbeat.com25,618 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Acquired by CenterBook Partners LPCenterBook Partners LP bought a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 25,618 shares of the medical research company'sApril 11 at 8:02 AM | marketbeat.comZacks Research Issues Positive Estimate for CRL EarningsCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Equities research analysts at Zacks Research lifted their Q2 2026 earnings per share (EPS) estimates for Charles River Laboratories International in a research note issued on Monday, April 7th. Zacks Research analyst R. DepApril 11 at 7:52 AM | marketbeat.comZacks Research Issues Pessimistic Estimate for CRL EarningsCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Equities research analysts at Zacks Research reduced their Q1 2025 earnings per share (EPS) estimates for shares of Charles River Laboratories International in a report issued on Monday, April 7th. Zacks Research analyst R.April 10, 2025 | marketbeat.comWells Fargo & Company MN Has $89.26 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Wells Fargo & Company MN trimmed its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 12.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 483,514 shares ofApril 10, 2025 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Sets New 12-Month Low - Here's WhyCharles River Laboratories International (NYSE:CRL) Reaches New 52-Week Low - What's Next?April 9, 2025 | marketbeat.comNational Bank of Canada FI Has $4.40 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)National Bank of Canada FI lifted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 12.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,855 shares ofApril 9, 2025 | marketbeat.comZacks Research Issues Pessimistic Forecast for CRL EarningsApril 9, 2025 | americanbankingnews.com5,150 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Acquired by Dynamic Technology Lab Private LtdDynamic Technology Lab Private Ltd purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 5,150 shares of the medApril 8, 2025 | marketbeat.comAfter A CRL Setback, Aldeyra Therapeutics Is A Compelling Speculative BuyApril 8, 2025 | seekingalpha.comRhenman & Partners Asset Management AB Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL)Rhenman & Partners Asset Management AB trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 60.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,850 shApril 7, 2025 | marketbeat.comGeode Capital Management LLC Has $227.04 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Geode Capital Management LLC increased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,233,211 shares of the meApril 7, 2025 | marketbeat.comBryce Point Capital LLC Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL)Bryce Point Capital LLC purchased a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,898 shares of theApril 6, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by California Public Employees Retirement SystemCalifornia Public Employees Retirement System cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 8.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor oApril 6, 2025 | marketbeat.comDF Dent & Co. Inc. Has $20.77 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)DF Dent & Co. Inc. trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 6.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 112,530 shares of the medical research company's stock after selling 7,515 shareApril 5, 2025 | marketbeat.comCinctive Capital Management LP Purchases Shares of 12,252 Charles River Laboratories International, Inc. (NYSE:CRL)Cinctive Capital Management LP acquired a new position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 12,252 shares of the medical research compaApril 5, 2025 | marketbeat.comJPMorgan Chase & Co. Has $85.32 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)JPMorgan Chase & Co. reduced its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 462,170 shares of the medical reApril 5, 2025 | marketbeat.comGroupama Asset Managment Raises Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Groupama Asset Managment lifted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 155.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,416 shares of the medical research cApril 4, 2025 | marketbeat.comFranklin Resources Inc. Sells 16,675 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Franklin Resources Inc. lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 647,780 shares oApril 4, 2025 | marketbeat.comCIBC Private Wealth Group LLC Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)CIBC Private Wealth Group LLC lessened its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 91.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,597 shares of the medical research company'sApril 4, 2025 | marketbeat.comNorges Bank Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL)Norges Bank bought a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 535,677 shares of the medical reseApril 3, 2025 | marketbeat.comThrivent Financial for Lutherans Sells 327,239 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Thrivent Financial for Lutherans cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 98.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,423April 3, 2025 | marketbeat.comTrexquant Investment LP Buys 81,714 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Trexquant Investment LP lifted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 440.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 100,277 shares of the medical research company'April 2, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Position Lifted by Wellington Management Group LLPWellington Management Group LLP raised its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 9.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,076,426 shares of the mediApril 2, 2025 | marketbeat.comKorea Investment CORP Sells 42,200 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Korea Investment CORP reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 61.6% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 26,304 shares of the medical research company's stock after selling 42,200April 2, 2025 | marketbeat.comPrudential Financial Inc. Sells 4,554 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Prudential Financial Inc. decreased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 13.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,29April 2, 2025 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Hits New 12-Month Low - Here's WhyCharles River Laboratories International (NYSE:CRL) Hits New 12-Month Low - Time to Sell?April 1, 2025 | marketbeat.comClearbridge Investments LLC Cuts Position in Charles River Laboratories International, Inc. (NYSE:CRL)Clearbridge Investments LLC reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 28.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 775,213 shares of the medical research company'April 1, 2025 | marketbeat.comUniSuper Management Pty Ltd Grows Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)UniSuper Management Pty Ltd lifted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 20.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,033 shares of the medical research company'sApril 1, 2025 | marketbeat.comMawer Investment Management Ltd. Buys 5,769 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Mawer Investment Management Ltd. lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 14.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 46,629 sMarch 31, 2025 | marketbeat.comHeartland Advisors Inc. Has $2.96 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Heartland Advisors Inc. cut its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 33.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 16,059 shares of the medical research coMarch 30, 2025 | marketbeat.com18,577 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Purchased by New Age Alpha Advisors LLCNew Age Alpha Advisors LLC bought a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 18,577 shares of the medical research company's stocMarch 30, 2025 | marketbeat.comMitsubishi UFJ Trust & Banking Corp Cuts Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Mitsubishi UFJ Trust & Banking Corp reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 10.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 92,471 shares of the mMarch 30, 2025 | marketbeat.comVanguard Group Inc. Has $1.14 Billion Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Vanguard Group Inc. lifted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,158,926 shares of the medical research company's stock afterMarch 30, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Receives Average Recommendation of "Reduce" from AnalystsShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have received a consensus recommendation of "Reduce" from the sixteen research firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendatMarch 30, 2025 | marketbeat.com Remove Ads Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼0.801.00▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼359▲CRL Articles Average Week Remove Ads Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Bio-Rad Laboratories News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe biggest story CNBC isn't talking about (yet)This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRL Stock Free CRL Stock Alerts